CLINICAL TRIALS PROFILE FOR LUMRYZ
✉ Email this page to a colleague
All Clinical Trials for LUMRYZ
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT07041203 ↗ | Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor | NOT_YET_RECRUITING | Kristina Simonyan | PHASE1 | 2026-03-01 | Using a comprehensive approach of clinico-behavioral testing and neuroimaging, the researchers will examine the clinical effects of the extended-release formulation of sodium oxybate on voice symptoms in spasmodic dysphonia in an open-label, proof-of-concept, dose-finding study. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LUMRYZ
Condition Name
Clinical Trial Locations for LUMRYZ
Trials by Country
Clinical Trial Progress for LUMRYZ
Clinical Trial Phase
Clinical Trial Sponsors for LUMRYZ
Sponsor Name
